# Thrombectomy Under Reopro Versus Alteplase to Treat Stoke

> **NCT02016547** · PHASE4 · TERMINATED · sponsor: **SOS Attaque Cérébrale** · enrollment: 40 (estimated)

## Conditions studied

- Infarction, Middle Cerebral Artery

## Interventions

- **PROCEDURE:** abciximab IV and thrombectomy
- **DRUG:** alteplase 0.9mg/kg (10% by IV bolus following by 90% by 1 hour IV drip)

## Key facts

- **NCT ID:** NCT02016547
- **Lead sponsor:** SOS Attaque Cérébrale
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-09
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02016547

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02016547, "Thrombectomy Under Reopro Versus Alteplase to Treat Stoke". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02016547. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*